Mirataz Exp Extension
Attached is a letter from Jan Cunningham, Dechra’s Director of Regulatory Affairs, North America, explaining the Mirataz®(mirtazapine transdermal ointment) shelf life extension, from 30 months to 48 months, which was approved by FDA in October 2019. The letter includes information…